Clinical Trial Update: the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating thalidomide for recurrent small intestinal bleeding due to gastrointestinal vascular malformation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Vascular Malformation
• Small Intestinal Bleeding

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Gastrointestinal Vascular Malformation | Phase 3 | Status: COMPLETED